These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 25845525)
21. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition. Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796 [TBL] [Abstract][Full Text] [Related]
22. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features. Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644 [TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA CPS1-IT1 is a positive prognostic factor and inhibits epithelial ovarian cancer tumorigenesis. Wang YS; Ma LN; Sun JX; Liu N; Wang H Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3169-3175. PubMed ID: 28770969 [TBL] [Abstract][Full Text] [Related]
24. Cysteine-rich, angiogenic inducer, 61 expression in patients with ovarian epithelial carcinoma. Lin Y; Xu T; Tian G; Cui M J Int Med Res; 2014 Apr; 42(2):300-6. PubMed ID: 24595148 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA let-7a modifies the effect of self-renewal gene HIWI on patient survival of epithelial ovarian cancer. Lu L; Katsaros D; Risch HA; Canuto EM; Biglia N; Yu H Mol Carcinog; 2016 Apr; 55(4):357-65. PubMed ID: 25630839 [TBL] [Abstract][Full Text] [Related]
26. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer. Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer. Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353 [TBL] [Abstract][Full Text] [Related]
28. Targeting HSF1 leads to an antitumor effect in human epithelial ovarian cancer. Chen YF; Wang SY; Yang YH; Zheng J; Liu T; Wang L Int J Mol Med; 2017 Jun; 39(6):1564-1570. PubMed ID: 28487934 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma. Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000 [TBL] [Abstract][Full Text] [Related]
30. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer. Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo. Zhang L; Li Z; Gai F; Wang Y Mol Med Rep; 2015 Aug; 12(2):3107-14. PubMed ID: 25955305 [TBL] [Abstract][Full Text] [Related]
32. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma. Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852 [TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer. Hong F; Li Y; Xu Y; Zhu L J Int Med Res; 2013 Feb; 41(1):64-71. PubMed ID: 23569131 [TBL] [Abstract][Full Text] [Related]
34. Upregulation of SENP3/SMT3IP1 promotes epithelial ovarian cancer progression and forecasts poor prognosis. Cheng J; Su M; Jin Y; Xi Q; Deng Y; Chen J; Wang W; Chen Y; Chen L; Shi N; Mao G Tumour Biol; 2017 Mar; 39(3):1010428317694543. PubMed ID: 28351334 [TBL] [Abstract][Full Text] [Related]
35. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer. Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196 [TBL] [Abstract][Full Text] [Related]
36. [Expression of lnc-MyD88 and its relationship with the prognosis of patients with epithelial ovarian cancer]. Zhu Y; Huang JM; Zhang GN; Li JM; Huang J Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):117-124. PubMed ID: 35184472 [No Abstract] [Full Text] [Related]
37. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p. Lin M; Xia B; Qin L; Chen H; Lou G DNA Cell Biol; 2018 May; 37(5):491-500. PubMed ID: 29485916 [TBL] [Abstract][Full Text] [Related]
38. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis. Yang M; Xie X; Ding Y Oncol Rep; 2016 Mar; 35(3):1796-806. PubMed ID: 26750614 [TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer. Cao Y; Shi H; Ren F; Jia Y; Zhang R Exp Cell Res; 2017 Oct; 359(1):185-194. PubMed ID: 28754469 [TBL] [Abstract][Full Text] [Related]
40. Immunohistological insight into the correlation between neuropilin-1 and epithelial-mesenchymal transition markers in epithelial ovarian cancer. Adham SA; Al Harrasi I; Al Haddabi I; Al Rashdi A; Al Sinawi S; Al Maniri A; Ba-Omar T; Coomber BL J Histochem Cytochem; 2014 Sep; 62(9):619-31. PubMed ID: 24850663 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]